RELIFEX

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Αγόρασέ το τώρα

Δραστική ουσία:

NABUMETONE

Διαθέσιμο από:

Imbat Limited

Φαρμακολογική κατηγορία (ATC):

M01AX01

INN (Διεθνής Όνομα):

NABUMETONE

Δοσολογία:

500 Milligram

Φαρμακοτεχνική μορφή:

Film Coated Tablet

Τρόπος διάθεσης:

Product subject to prescription which may be renewed (B)

Θεραπευτική περιοχή:

nabumetone

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2009-11-13

Φύλλο οδηγιών χρήσης

                                Page 1 of 2
PACKAGE LEAFLET: INFORMATION FOR THE USER
RELIFEX
® 500MG FILM-COATED TABLETS
(nabumetone)
The name of your medicine is Relifex 500mg film coated
tablets, but will be referred to as Relifex tablets throughout
this leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or
pharmacist.

This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their
signs of illness are the same as yours.

If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Relifex tablets are and what they are used for
2.
What you need to know before you take Relifex tablets
3.
How you take Relifex tablets
4.
Possible side effects
5.
How to store Relifex tablets
6.
Contents of the pack and other information
1.
WHAT RELIFEX TABLETS ARE AND WHAT THEY ARE
USED FOR
Relifex tablets contain the active ingredient nabumetone,
which belongs to a group of medicines called non-steroidal
anti-inflammatory drugs (NSAIDs).
Relifex tablets are used for the management of arthritis such
as:

Osteoarthritis

Rheumatoid arthritis

Spondylitis (inflammation of the spine)

Gout (inflammation of a joint - often the big toe) and

Muscle injuries
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE
RELIFEX TABLETS
DO NOT TAKE RELIFEX TABLETS:

If you are allergic to Nabumetone.

If you have experienced asthma, hives or an allergic
reaction to other similar drugs (NSAIDs).

If you are allergic to any of the other ingredients of
Relifex tablets (listed in section 6). An allergic reaction
may include rash, itching, difficulty breathing or swelling
of the face, lips, throat or tongue.

If you have or have had a peptic ulcer (ulcer in your
stomach or duodenum) or bleeding in your stomach (2
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Αρχείο Π.Χ.Π.

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Relifex 500mg Film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 500mg of nabumetone.
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet.
_Product imported from the UK:_
Dark red, film-coated tablets marked “Relifex” on one side and
“500” on the other.
4 CLINICAL PARTICULARS
As per PA1051/001/001
5 PHARMACOLOGICAL PROPERTIES
As per PA1051/001/001
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
Sodium starch glycollate
Sodium lauryl sulphate
Hypromellose
Magnesium stearate
Microcrystalline cellulose
Saccharin sodium
Liquid caramel flavour
Red carmine (E120)
Iron oxide yellow (E172)
Titanium dioxide (E171)
Talc
Polyethylene glycol 400
Carnauba wax
6.2 INCOMPATIBILITIES
Not applicable.
6.3 SHELF LIFE
The shelf life expiry date of this product is the date shown on the
blister strips and outer carton of the product as
marketed in the country of origin
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_2_
_1_
_6_
_5_
_7_
_9_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
6.4 SPECIAL PRECAUTIONS FOR STORAGE
Keep the tablets in the original container in order to protect from
light.
6.5 NATURE AND CONTENTS OF CONTAINER
Cardboard outer containing a plastic bottle with a screw top cap.
Pack size: 56 tablets.
6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR
WASTE
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Αναζήτηση ειδοποιήσεων που σχετίζονται με αυτό το προϊόν

Προβολή ιστορικού εγγράφων